WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (AMEX: ILI) today announced that it will release its third quarter financial results on Wednesday, November 8 after the market closes. The Company’s management will host the conference call at 4:30 PM EST to review Interleukin’s financial results and provide a general Company update.
